These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7959366)

  • 1. Molecular genetics aspects of factor XI deficiency and Glanzmann thrombasthenia.
    Seligsohn U; Peretz H
    Haemostasis; 1994; 24(2):81-5. PubMed ID: 7959366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.
    Peretz H; Mulai A; Usher S; Zivelin A; Segal A; Weisman Z; Mittelman M; Lupo H; Lanir N; Brenner B; Shpilberg O; Seligsohn U
    Blood; 1997 Oct; 90(7):2654-9. PubMed ID: 9326232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glanzmann thrombasthenia caused by an 11.2-kb deletion in the glycoprotein IIIa (beta3) is a second mutation in Iraqi Jews that stemmed from a distinct founder.
    Rosenberg N; Yatuv R; Orion Y; Zivelin A; Dardik R; Peretz H; Seligsohn U
    Blood; 1997 May; 89(10):3654-62. PubMed ID: 9160670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews.
    Shpilberg O; Peretz H; Zivelin A; Yatuv R; Chetrit A; Kulka T; Stern C; Weiss E; Seligsohn U
    Blood; 1995 Jan; 85(2):429-32. PubMed ID: 7811996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XI deficiency in Ashkenazi Jews in Israel.
    Asakai R; Chung DW; Davie EW; Seligsohn U
    N Engl J Med; 1991 Jul; 325(3):153-8. PubMed ID: 2052060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.
    Newman PJ; Seligsohn U; Lyman S; Coller BS
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3160-4. PubMed ID: 2014236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the Glanzmann's thrombasthenia mutations in Arab and Iraqi-Jewish patients by polymerase chain reaction and restriction analysis of blood or urine samples.
    Peretz H; Seligsohn U; Zwang E; Coller BS; Newman PJ
    Thromb Haemost; 1991 Oct; 66(4):500-4. PubMed ID: 1796402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two common mutations causing factor XI deficiency in Ashkenazi Jews may point to a European origin.
    Zoossmann-Diskin A
    Blood; 1995 Oct; 86(8):3267-8. PubMed ID: 7579427
    [No Abstract]   [Full Text] [Related]  

  • 9. Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews.
    Peretz H; Salomon O; Mor-Cohen R; Usher S; Zucker M; Zivelin A; Seligsohn U
    J Thromb Haemost; 2013 Apr; 11(4):724-30. PubMed ID: 23332144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glanzmann thrombasthenia in two Iraqi-Jewish siblings is caused by a novel splice junction mutation in the glycoprotein IIb.
    Yatuv R; Rosenberg N; Dardik R; Brenner B; Seligsohn U
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):285-8. PubMed ID: 9663713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inherited bleeding disorders common in Jews].
    Seligsohn U
    Harefuah; 2010 May; 149(5):298-303, 335. PubMed ID: 20929069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews.
    Goldstein DB; Reich DE; Bradman N; Usher S; Seligsohn U; Peretz H
    Am J Hum Genet; 1999 Apr; 64(4):1071-5. PubMed ID: 10090892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients.
    Zadra G; Asselta R; Malcovati M; Santagostino E; Peyvandi F; Mannucci PM; Tenchini ML; Duga S
    Haematologica; 2004 Nov; 89(11):1332-40. PubMed ID: 15531455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel.
    Coller BS; Cheresh DA; Asch E; Seligsohn U
    Blood; 1991 Jan; 77(1):75-83. PubMed ID: 1702031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis.
    Coller BS; Seligsohn U; Little PA
    Blood; 1987 Jun; 69(6):1696-703. PubMed ID: 3580574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia.
    Yatuv R; Rosenberg N; Zivelin A; Peretz H; Dardik R; Trakhtenbrot L; Seligsohn U
    Blood; 2001 Aug; 98(4):1063-9. PubMed ID: 11493452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency.
    Bolton-Maggs PH; Peretz H; Butler R; Mountford R; Keeney S; Zacharski L; Zivelin A; Seligsohn U
    J Thromb Haemost; 2004 Jun; 2(6):918-24. PubMed ID: 15140127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians.
    Zadra G; Asselta R; Tenchini ML; Castaman G; Seligsohn U; Mannucci PM; Duga S
    Haematologica; 2008 May; 93(5):715-21. PubMed ID: 18387979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular genetic study of factor XI deficiency.
    Hancock JF; Wieland K; Pugh RE; Martinowitz U; Schulman S; Kakkar VV; Kernoff PB; Cooper DN
    Blood; 1991 May; 77(9):1942-8. PubMed ID: 2018835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.
    Asakai R; Chung DW; Ratnoff OD; Davie EW
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7667-71. PubMed ID: 2813350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.